These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 34075664)

  • 1. Exacerbation of subacute cutaneous lupus erythematosus following vaccination with BNT162b2 mRNA vaccine.
    Niebel D; Ralser-Isselstein V; Jaschke K; Braegelmann C; Bieber T; Wenzel J
    Dermatol Ther; 2021 Jul; 34(4):e15017. PubMed ID: 34075664
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction and exacerbation of subacute cutaneous lupus erythematosus following mRNA-based or adenoviral vector-based SARS-CoV-2 vaccination.
    Kreuter A; Licciardi-Fernandez MJ; Burmann SN; Burkert B; Oellig F; Michalowitz AL
    Clin Exp Dermatol; 2022 Jan; 47(1):161-163. PubMed ID: 34291477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous lupus-erythematosus-like reaction arising after COVID-19 vaccination.
    Rose C; Apgar R; Green M
    J Cutan Pathol; 2022 Nov; 49(11):943-946. PubMed ID: 35754159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subacute cutaneous lupus erythematosus induced by Pfizer COVID-19 vaccine.
    Magnaterra E; Magliulo M; Mariotti EB; Ruffo DI Calabria V; Quintarelli L; Corrà A; Aimo C; Verdelli A; Caproni M
    Ital J Dermatol Venerol; 2023 Jun; 158(3):266-267. PubMed ID: 36881332
    [No Abstract]   [Full Text] [Related]  

  • 5. Subacute cutaneous lupus erythematosus flare triggered by COVID-19 vaccine.
    Joseph AK; Chong BF
    Dermatol Ther; 2021 Nov; 34(6):e15114. PubMed ID: 34455671
    [No Abstract]   [Full Text] [Related]  

  • 6. New-onset systemic lupus erythematosus following BNT162b2 mRNA COVID-19 vaccine: a case series and literature review.
    Sagy I; Zeller L; Raviv Y; Porges T; Bieber A; Abu-Shakra M
    Rheumatol Int; 2022 Dec; 42(12):2261-2266. PubMed ID: 36098769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiomyopathy following COVID-19 vaccination in a patient with systemic lupus erythematosus.
    Bhullar AK; Chew ZC; Ong PS; Khor CG; Mohd Amin NH
    Mod Rheumatol Case Rep; 2023 Jan; 7(1):87-91. PubMed ID: 36069645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse events of special interest and mortality following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines in Hong Kong: A retrospective study.
    Wong CKH; Lau KTK; Xiong X; Au ICH; Lai FTT; Wan EYF; Chui CSL; Li X; Chan EWY; Gao L; Cheng FWT; Tang SCW; Wong ICK
    PLoS Med; 2022 Jun; 19(6):e1004018. PubMed ID: 35727759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 Vaccine.
    Cyrenne BM; Al-Mohammedi F; DeKoven JG; Alhusayen R
    J Eur Acad Dermatol Venereol; 2021 Sep; 35(9):e546-e548. PubMed ID: 33982814
    [No Abstract]   [Full Text] [Related]  

  • 10. Why two doses of the BNT162b2 mRNA COVID-19 vaccine? A different strategy to speed up the vaccination process: single-dose of the BNT162b2 mRNA COVID-19 and other vaccines.
    LA Vecchia C; Centanni S; Gerli AG
    Panminerva Med; 2022 Mar; 64(1):131-132. PubMed ID: 33480519
    [No Abstract]   [Full Text] [Related]  

  • 11. Subacute cutaneous lupus erythematosus after COVID-19 vaccine.
    Wang YJ; Hui HZ; Cheng JR; Mao H; Shi BJ
    Int J Rheum Dis; 2023 Jul; 26(7):1407-1409. PubMed ID: 36880735
    [No Abstract]   [Full Text] [Related]  

  • 12. Epidemiology of Myocarditis and Pericarditis Following mRNA Vaccination by Vaccine Product, Schedule, and Interdose Interval Among Adolescents and Adults in Ontario, Canada.
    Buchan SA; Seo CY; Johnson C; Alley S; Kwong JC; Nasreen S; Calzavara A; Lu D; Harris TM; Yu K; Wilson SE
    JAMA Netw Open; 2022 Jun; 5(6):e2218505. PubMed ID: 35749115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subacute cutaneous lupus erythematosus triggered after measles vaccination.
    de Mattos ABN; Garbo Baroni L; Zanotto LL; Furian MEA
    Lupus; 2021 Apr; 30(5):833-835. PubMed ID: 33573457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of Inactivated and mRNA COVID-19 Vaccination Among Patients Treated for Hypothyroidism: A Population-Based Cohort Study.
    Xiong X; Wong CKH; Au ICH; Lai FTT; Li X; Wan EYF; Chui CSL; Chan EWY; Cheng FWT; Lau KTK; Lee CH; Woo YC; Lui DTW; Wong ICK
    Thyroid; 2022 May; 32(5):505-514. PubMed ID: 35216517
    [No Abstract]   [Full Text] [Related]  

  • 15. Asymptomatic infection after BNT162b2 mRNA COVID-19 vaccination in multiple sclerosis patient.
    Jakimovski D; Weinstock-Guttman B
    Acta Neurol Belg; 2022 Apr; 122(2):565-566. PubMed ID: 34529258
    [No Abstract]   [Full Text] [Related]  

  • 16. Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease.
    Beckley M; Olson AK; Portman MA
    JAMA Netw Open; 2022 Aug; 5(8):e2226236. PubMed ID: 35960521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New-onset cutaneous lupus erythematosus after the COVID-19 vaccine.
    Liu V; Messenger NB
    Dermatol Online J; 2021 Nov; 27(11):. PubMed ID: 35130405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are the Allergic Reactions of COVID-19 Vaccines Caused by mRNA Constructs or Nanocarriers? Immunological Insights.
    Selvaraj G; Kaliamurthi S; Peslherbe GH; Wei DQ
    Interdiscip Sci; 2021 Jun; 13(2):344-347. PubMed ID: 34021862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SCLE manifestation after mRNA COVID-19 vaccination.
    Rechtien L; Erfurt-Berge C; Sticherling M
    J Eur Acad Dermatol Venereol; 2022 Apr; 36(4):e261-e263. PubMed ID: 34928536
    [No Abstract]   [Full Text] [Related]  

  • 20. Association study between herpes zoster reporting and mRNA COVID-19 vaccines (BNT162b2 and mRNA-1273).
    Préta LH; Contejean A; Salvo F; Treluyer JM; Charlier C; Chouchana L
    Br J Clin Pharmacol; 2022 Jul; 88(7):3529-3534. PubMed ID: 35174524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.